Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000008

Director sold 20,000 shares at an average $28.85 ($577,093)

  • Director acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schenkein David P · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-17 Exercise or conversion : show line 1 in the form +20,000 $9.05 $181,000 137,879 D
2023-01-17 Sale : show line 2 in the form −18,966 $28.82 $546,600 118,913 D
2023-01-17 Sale : show line 3 in the form −1,034 $29.49 $30,493 117,879 D
Open-market sales · 20,000 sh · avg $28.85 · $577,093

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-17 Exercise or conversion : show line 4 in the form Stock option (right to buy) −20,000 116,363 D
Loading xslF345X03/wf-form4_167416220784481.xml…